CONTROLLED SUBSTANCES ACT

Amendments

Drugs: clarify definition of anabolic steroids and provide for research and education activities relative to steroids (S. 2195), S10602, S10606 [6OC]

Bills and resolutions

Drugs: allow for immediate seizure and destruction of controlled substances being illegally imported into the U.S. (see S. 2465), S5949 [20MY]

———clarify definition of anabolic steroids and provide for research and education activities relative to steroids (see S. 2195), S2716 [11MR]

———increase penalties for anabolic steroid offenses near sports facilities (see H.R. 3866), H707 [1MR]

———lift the patient limitation on prescribing drug addiction treatments by medical practitioners in group practices (see S. 2897), S10436 [5OC] (see S. 2976), S11305 [11OC]

———provide an affirmative defense for medical use of marijuana in Federal criminal trials occuring in States with medical marijuana use laws (see S. 2989), S11429 [17NO]

FDA: regulation of ephedrine alkaloids, including ephedrine and pseudoesphedrine (see H.R. 4395), H3390 [19MY]

Law enforcement: protect vulnerable persons from drug trafficking (see H.R. 4547), H3962 [14JN]

———treat drug offenses involving crystal methamphetamine similarly to drug offenses involving crack cocaine (see S. 2444), S5799 [19MY]

Letters

Scheduling substances under the Controlled Substances Act: Karen P. Tandy, DEA, S10609 [6OC]

Remarks in House

Drugs: clarify definition of anabolic steroids and provide for research and education activities relative to steroids (S. 2195), H9010 [8OC]

———increase penalties for anabolic steroid offenses near sports facilities (H.R. 3866), H3660-H3665 [2JN]

Remarks in Senate

Drugs: allow for immediate seizure and destruction of controlled substances being illegally imported into the U.S. (S. 2465), S5983-S5985 [20MY]

———clarify definition of anabolic steroids and provide for research and education activities relative to steroids (S. 2195), S10606-S10609 [6OC], S10686 [7OC]

———lift the patient limitation on prescribing drug addiction treatments by medical practitioners in group practices (S. 1887), S6490 [7JN], S6624 [8JN]

———lift the patient limitation on prescribing drug addiction treatments by medical practitioners in group practices (S. 2976), S11260, S11261 [11OC]

———provide an affirmative defense for medical use of marijuana in Federal criminal trials occuring in States with medical marijuana use laws (S. 2989), S11430 [17NO], S11609 [19NO]

Reports filed

Anabolic Steroid Control Act: Committee on Energy and Commerce (House) (H.R. 3866) (H. Rept. 108-461), H2405 [27AP]

———Committee on the Judiciary (House) (H.R. 3866) (H. Rept. 108-461), H2151 [2AP]

———Committee on the Judiciary (Senate) (S. 2195), S10059 [30SE]

Lift the Patient Limitation on Prescribing Drug Addiction Treatments by Medical Practitioners in Group Practices: Committee on the Judiciary (Senate) (S. 1887), S6450 [3JN]

Statements

DEA Raid Relative to Use of Medical Marijuana: Suzanne Pfeil, Wo/Men's Alliance for Medical Marijuana, S11431 [17NO]

Texts of

H.R. 3866, Anabolic Steroid Control Act, H3660 [2JN]

S. 1887, lift the patient limitation on prescribing drug addiction treatments by medical practitioners in group practices, S6490 [7JN]

S. 2195, Anabolic Steroid Control Act, S10606-S10608 [6OC], H9010 [8OC]

S. 2976, lift the patient limitation on prescribing drug addiction treatments by medical practitioners in group practices, S11261 [11OC]